•Rosen Law Firm, a global investor rights law firm, is investigating potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP).
•The investigation focuses on allegations that Immutep may have issued materially misleading business information to the investing public.
•The investigation notice was published on April 15, 2026.
•Kimberly-Clark announced a new organizational structure featuring four geographic business segments: North America, Asia Pacific Focus Markets, EMEA, and Enterprise Markets.
•Mike Hsu will continue as Chairman and CEO of the combined entity, which will include brands like Kleenex and Tylenol.
•The new structure aims to increase agility and speed to capitalize on growth opportunities in the health and wellness sector.